Safety of sodium-glucose cotransporter 2 inhibitors (SGLT2i) during the month of Ramadan in patients with type 2 diabetes mellitus in Pakistani population—an observational study from a tertiary care center in Karachi

BACKGROUND AND AIMS: Primary aim was to assess the safety of SGLT2-i in patients with Type 2 Diabetes Mellitus (T2D) in a real-life scenario during Ramadan by finding the frequency and severity of hypoglycemic/hyperglycemic events, dehydration, and Diabetic ketoacidosis (DKA). Secondary aim was to a...

Descripción completa

Detalles Bibliográficos
Autores principales: Sheikh, Aisha, Das, Bhagwan, Sattar, Saadia, Islam, Najmul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9798932/
https://www.ncbi.nlm.nih.gov/pubmed/36580199
http://dx.doi.org/10.1007/s12020-022-03290-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9798932/
https://www.ncbi.nlm.nih.gov/pubmed/36580199
http://dx.doi.org/10.1007/s12020-022-03290-7

Ejemplares similares